Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
pharmaphorum5y
Novo’s new oral GLP-1 Rybelsus still has obstacles to overcome
with Rybelsus having the potential to go even higher. Novo Nordisk has some data suggesting its oral drug was better than Trulicity at controlling blood glucose control and achieving weight loss ...